Frontlight ResearchEarly access
Trial site
Ghent
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis2 trials
- Acute myeloid leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Epilepsy1 trial
- Familial hypercholesterolaemia1 trial
- Multiple myeloma1 trial
- Psoriatic arthritis1 trial
- Phase
- Phase 35 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals7 trials
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Closed trials
Terminated
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 17 Nov 2026